top of page

Maharashtra Cancels Johnson & Johnson's Baby Powder Licence Over Health Concerns

Sep 17, 2022, 08:00 am

In the wake of skin safety of newborn babies Maharashtra's Food and Drugs Administration (FDA) on Friday cancelled the baby powder manufacturing licence of Johnson & Johnson Pvt Ltd.

Samples of powder in laboratory testing did not conform to standard pH which might in turn be of a concern for the skins of babies.

The release said the action was taken after Kolkata-based Central Drugs Laboratory's conclusive report that concludes "the sample does not conform to IS 5339:2004 with respect to the test for pH".

According to the release, FDA had drawn samples of Johnson's Baby Powder from Pune and Nashik for quality check purposes.

The government analyst had declared the samples as "not of the standard quality" as they do not comply with IS 5339:2004 specification for skin powder for infants in the test pH, it said.

Thereafter, FDA issued a show-cause notice to Johnson and Johnson under the Drugs Cosmetics Act 1940 and Rules, besides issuing instructions to the company to recall the stock of the said product from market, said the release.

The firm "didn't accept the report" of the government analyst and challenged it in court for sending it to the Central Drugs Laboratory, it added.

bottom of page